{
  "clubs": [
    {
      "name": "Al Nassr",
      "id": 1,
      "logo_img_url": "/assets/images/clubs/nasr-logo.webp",
      "name_img_url": "/assets/images/clubs/nasr-name.webp",
      "card_img_url": "/assets/images/clubs/nasr-card.webp"
    },
    {
      "name": "Al Hilal",
      "id": 2,
      "logo_img_url": "/assets/images/clubs/hilal-logo.webp",
      "name_img_url": "/assets/images/clubs/hilal-name.webp",
      "card_img_url": "/assets/images/clubs/hilal-card.webp"
    },
    {
      "name": "Real Madrid",
      "id": 3,
      "logo_img_url": "/assets/images/clubs/madrid-logo.webp",
      "name_img_url": "/assets/images/clubs/madrid-name.webp",
      "card_img_url": "/assets/images/clubs/madrid-card.webp"
    },
    {
      "name": "Barcelona",
      "id": 4,
      "logo_img_url": "/assets/images/clubs/barcelona-logo.webp",
      "name_img_url": "/assets/images/clubs/barcelona-name.webp",
      "card_img_url": "/assets/images/clubs/barcelona-card.webp"
    }
  ],
  "questions": {
    "speed_question": {
      "audio_url": "/audios/vonjo/speed_question.mp3",
      "question": "Which country has won the most FIFA World Cups in history?",
      "answers": [
        {
          "answer": "Germany",
          "is_correct": false,
          "id": 1
        },
        {
          "answer": "Argentina",
          "is_correct": false,
          "id": 2
        },
        {
          "answer": "Brazil",
          "is_correct": true,
          "id": 3
        },
        {
          "answer": "Italy",
          "is_correct": false,
          "id": 4
        }
      ]
    },
    "magic_questions": {
      "team1": {
        "audio_url": "/audios/vonjo/magic-question-1.mp3",
        "question": "in PERSIST 2 Study ...... of patients on VONJO were anemic (Hgb <10 g/dL)",
        "answers": [
          {
            "answer": "55%",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "59%",
            "is_correct": true,
            "id": 2
          },
          {
            "answer": "62%",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "65%",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      "team2": {
        "audio_url": "/audios/vonjo/magic-question-2.mp3",
        "question": "in PERSIST 2 Study : Proportion of patients with reduced RBC transfusion burden at Week 24 with VONJO 200 mg BID",
        "answers": [
          {
            "answer": "25%",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "22%",
            "is_correct": true,
            "id": 2
          },
          {
            "answer": "27%",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "20%",
            "is_correct": false,
            "id": 4
          }
        ]
      }
    },
    "main_questions": [
      {
        "id": 1,
        "img_url": "/assets/images/players/ronaldo.webp",
        "audio_url": "/audios/vonjo/sa_national_sport.mp3",
        "points": 350,
        "question": "Which sport is considered South Africa's most popular and historically significant national sport?",
        "answers": [
          {
            "answer": "Soccer",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "Cricket",
            "is_correct": false,
            "id": 2
          },
          {
            "answer": "Rugby",
            "is_correct": true,
            "id": 3
          },
          {
            "answer": "Field Hockey",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 2,
        "img_url": "/assets/images/players/neymar.webp",
        "audio_url": "/audios/vonjo/nccn_guidelines_symptoms.mp3",
        "points": 350,
        "question": "per NCCN Guidelines, vonjo is the treatment option for patients with symptomatic MF-associated anemia with symptoms not controlled",
        "answers": [
          {
            "answer": "2A",
            "is_correct": true,
            "id": 1
          },
          {
            "answer": "2B",
            "is_correct": false,
            "id": 2
          },
          {
            "answer": "1B",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "1A",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 3,
        "img_url": "/assets/images/players/mo.webp",
        "audio_url": "/audios/vonjo/persist2_rbc_transfusion.mp3",
        "points": 350,
        "question": "In PERSIST 2 Study, ....% of patients were RBC transfusion dependent",
        "answers": [
          {
            "answer": "20%",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "23%",
            "is_correct": true,
            "id": 2
          },
          {
            "answer": "59%",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "55%",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 4,
        "img_url": "/assets/images/players/robert.webp",
        "audio_url": "/audios/vonjo/persist2_median_dose.mp3",
        "points": 350,
        "question": "In PERSIST 2 Study, Median VONJO daily dose was ....... mg",
        "answers": [
          {
            "answer": "400",
            "is_correct": true,
            "id": 1
          },
          {
            "answer": "380",
            "is_correct": false,
            "id": 2
          },
          {
            "answer": "360",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "350",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 5,
        "img_url": "/assets/images/players/salem.webp",
        "audio_url": "/audios/vonjo/momelotinib_dose_reduction.mp3",
        "points": 250,
        "question": "For patients with platelet counts 20-<50 x 10^9/L on treatment by Momelotinib, Reduce daily dose by ...... mg from the last given dose",
        "answers": [
          {
            "answer": "100",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "50",
            "is_correct": true,
            "id": 2
          },
          {
            "answer": "25",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "75",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 6,
        "img_url": "/assets/images/players/sadio.webp",
        "audio_url": "/audios/vonjo/ruxolitinib_bat_arm.mp3",
        "points": 250,
        "question": "What is share of Ruxolitinib among BAT arm in PERSIST 2",
        "answers": [
          {
            "answer": "45%",
            "is_correct": true,
            "id": 1
          },
          {
            "answer": "50%",
            "is_correct": false,
            "id": 2
          },
          {
            "answer": "55%",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "40%",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 7,
        "img_url": "/assets/images/players/vinicius.webp",
        "audio_url": "/audios/vonjo/persist2_primary_mf.mp3",
        "points": 250,
        "question": "In PERSIST 2 Study Disease history: .......% of patients had primary MF",
        "answers": [
          {
            "answer": "55%",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "68%",
            "is_correct": true,
            "id": 2
          },
          {
            "answer": "72%",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "76%",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 8,
        "img_url": "/assets/images/players/pedri.webp",
        "audio_url": "/audios/vonjo/pacritinib_acvr1_potency.mp3",
        "points": 250,
        "question": "Pacritinib is ...... more potent than momelotinib against ACVR1",
        "answers": [
          {
            "answer": "3.5X",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "2.5X",
            "is_correct": false,
            "id": 2
          },
          {
            "answer": "4X",
            "is_correct": true,
            "id": 3
          },
          {
            "answer": "3X",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 9,
        "img_url": "/assets/images/players/malcom.webp",
        "audio_url": "/audios/vonjo/thrombocytopenia_prevalence.mp3",
        "points": 100,
        "question": "Prevalence of thrombocytopenia in patients with MF rises over time up to ........at any time during disease course",
        "answers": [
          {
            "answer": "60%",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "70%",
            "is_correct": true,
            "id": 2
          },
          {
            "answer": "80%",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "90%",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 10,
        "img_url": "/assets/images/players/otavio.webp",
        "audio_url": "/audios/vonjo/nccn_high_risk_mf.mp3",
        "points": 100,
        "question": "NCCN Guidelines : Vonjo is the recommended option for \u226550 x 10^9/L higher-risk MF",
        "answers": [
          {
            "answer": "TRUE",
            "is_correct": true,
            "id": 1
          },
          {
            "answer": "FALSE",
            "is_correct": false,
            "id": 2
          }
        ]
      },
      {
        "id": 11,
        "img_url": "/assets/images/players/luka.webp",
        "audio_url": "/audios/vonjo/persist2_co_primary_endpoint.mp3",
        "points": 100,
        "question": "PERSIST 2 Study co-primary end point",
        "answers": [
          {
            "answer": "SVR \u226535% by MRI/CT",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "\u226550% reduction in TSS",
            "is_correct": false,
            "id": 2
          },
          {
            "answer": "Changes in hematologic parameters",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "A+B",
            "is_correct": true,
            "id": 4
          }
        ]
      },
      {
        "id": 12,
        "img_url": "/assets/images/players/gavi.webp",
        "audio_url": "/audios/vonjo/ruxolitinib_dosage_limit.mp3",
        "points": 100,
        "question": "Real-world prescription data reveals .........% of ruxolitinib dosing is limited to 5 or 10 mg BID",
        "answers": [
          {
            "answer": "60%",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "62%",
            "is_correct": true,
            "id": 2
          },
          {
            "answer": "67%",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "70%",
            "is_correct": false,
            "id": 4
          }
        ]
      },
      {
        "id": 13,
        "img_url": "/assets/images/players/ali.webp",
        "audio_url": "/audios/vonjo/ruxolitinib_failure_definition.mp3",
        "points": 50,
        "question": "Defining Ruxolitinib Failure and Loss of Response",
        "answers": [
          {
            "answer": "Primary Refractory",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "Loss of Response or Progressive Disease",
            "is_correct": false,
            "id": 2
          },
          {
            "answer": "Intolerance",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "All of the above",
            "is_correct": true,
            "id": 4
          }
        ]
      },
      {
        "id": 14,
        "img_url": "/assets/images/players/abdulrahman.webp",
        "audio_url": "/audios/vonjo/vonjo_targets.mp3",
        "points": 50,
        "question": "Vonjo targets JAK1, JAK2, FLT3, IRAK1, ACVR1",
        "answers": [
          {
            "answer": "TRUE",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "FALSE",
            "is_correct": true,
            "id": 2
          }
        ]
      },
      {
        "id": 15,
        "img_url": "/assets/images/players/lucas.webp",
        "audio_url": "/audios/vonjo/vonjo_platelet_study.mp3",
        "points": 50,
        "question": "VONJO was studied in patients with platelet counts \u2264100 x 10^9/L with or without anemia",
        "answers": [
          {
            "answer": "\u226430 x 10^9/L",
            "is_correct": false,
            "id": 1
          },
          {
            "answer": "\u2264200 x 10^9/L",
            "is_correct": false,
            "id": 2
          },
          {
            "answer": "\u226450 x 10^9/L",
            "is_correct": false,
            "id": 3
          },
          {
            "answer": "\u2264100 x 10^9/L",
            "is_correct": true,
            "id": 4
          }
        ]
      },
      {
        "id": 16,
        "img_url": "/assets/images/players/sergi.webp",
        "audio_url": "/audios/vonjo/diarrhea_pacritinib.mp3",
        "points": 50,
        "question": "Diarrhea with pacritinib mostly occurred during weeks 1\u20138, was manageable with anti-diarrheals and generally resolved within 1\u20132 weeks",
        "answers": [
          {
            "answer": "TRUE",
            "is_correct": true,
            "id": 1
          },
          {
            "answer": "FALSE",
            "is_correct": false,
            "id": 2
          }
        ]
      }
    ]
  }
}